Jencycla (Lupin Pharmaceuticals, Inc.)
Welcome to the PulseAid listing for the Jencycla drug offered from Lupin Pharmaceuticals, Inc.. This Progesterone Congeners [Chemical/Ingredient],Progestin [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Lupin Pharmaceuticals, Inc. |
NON-PROPRIETARY NAME: | norethindrone |
SUBSTANCE NAME: | NORETHINDRONE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Progesterone Congeners [Chemical/Ingredient],Progestin [EPC] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2013-05-08 |
END MARKETING DATE: | 0000-00-00 |
Jencycla HUMAN PRESCRIPTION DRUG Details:
Item Description | Jencycla from Lupin Pharmaceuticals, Inc. |
LABELER NAME: | Lupin Pharmaceuticals, Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 0.35(mg/1) |
START MARKETING DATE: | 2013-05-08 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 68180-877_67a1856e-7887-4cf2-a209-b8f50a9f59cf |
PRODUCT NDC: | 68180-877 |
APPLICATION NUMBER: | ANDA091323 |
Other NORETHINDRONE Pharmaceutical Manufacturers / Labelers: